ipamorelin (10mg) CJC-1295 NO DAC (5mg) +
Description
Liu H, Shi W, Jin Z, Zhuo R, Dong J, Lao Q, et al
2020;12(9) doi: 10.3390/nu12092653
Author contributions JS: Conceptualization, Data curation, Funding acquisition, Investigation, Methodology, Visualization, Writingoriginal draft
10.1002/jbm.a.35548 99 HouC.-C.ZhuJ.-Q
The reduction in -hydroxybutyrate levels indicates potential as an early diagnostic marker for pancreatic neoplasms, suggesting that monitoring these levels may enhance early diagnosis and therapy approaches
